Navigation Links
IDRI and Medicago to present data at the World Vaccine Congress
Date:4/9/2013

SEATTLE and QUEBEC CITY, April 9, 2013 /PRNewswire/ -- IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that they will be presenting positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate "H5N1 vaccine" at the World Vaccine Congress. The meeting is being held at the Gaylord National Hotel and Convention Center in Washington, DC, April 16-18, 2013.

(Logo: http://photos.prnewswire.com/prnh/20120222/DC58319LOGO)

Dr. Steven Reed , Founder, President, & Chief Scientific Officer, IDRI, and Dr. Brian Ward , Professor of Medicine & Microbiology, McGill University, member of Medicago's scientific advisory committee, will be presenting at the World Vaccine Congress on April 17, 2013, at 2:35 p.m. EDT. The presentation, titled "H5N1 Phase 1 clinical trial combining Medicago's VLP vaccine with IDRI's GLA adjuvant formulation," will discuss preliminary safety and immunology data from the ongoing H5N1 vaccine clinical trial.

The Phase I clinical trial, which commenced in September 2012, enrolled 100 healthy adult volunteers, aged 18-49 years, at three locations in the U.S., testing for safety and immune response. The vaccine was also tested in comparison to Medicago's H5N1 vaccine with alum. The trial is funded by a multi-million dollar grant IDRI received from the Defense Advanced Research Projects Agency (DARPA), a division of the United Sta
'/>"/>

SOURCE Infectious Disease Research Institute (IDRI)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
4. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
5. Cardium Presents Year-End 2012 Financial Results And Recent Developments
6. Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
7. Pharmagen Presents to North Carolina General Assembly at N.C. Bios Legislative Breakfast
8. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. Dr. Kevin Foley to Present DiscGenics Recent Findings at the Lumbar Spine Research Societys Annual Meeting
11. Cynosure Announces Presentation of 16 Abstracts at 33rd ASLMS Annual Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014  Particle Sciences, Inc (PSI), the leading ... manufactured a new innovative vaginal ring for Ladee ... arm of Exeltis Pharmaceuticals.  According to Bruce ... Particle Sciences, "This vaginal ring was developed for ... and modeling expertise.  We are thrilled it is ...
(Date:11/21/2014)... Md. , Nov. 21, 2014  The University ... will host the ceremonial groundbreaking of the new A. ... Park. The new building will cultivate transformative new engineering ... Taking place at 10:00 a.m. on November ... the Paint Branch Parking Lot, adjacent to the Jeong ...
(Date:11/21/2014)... , Nov. 21, 2014   Rock Creek ... that the Company is scheduled to present at the ... Francisco, CA on January 12-14, 2015. ... and CEO of Rock Creek Pharmaceuticals, will present preclinical ... cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... NEWTON, Mass.--(BUSINESS WIRE)--Apr 16, 2007 - Novelos,Therapeutics, ... the development of therapeutics to treat cancer ... collaboration with,Dr. Kenneth Tew and Dr. Danyelle ... (MUSC), is making two poster presentations at ...
... CAMBRIDGE, Mass., April 16, 2007 /PRNewswire-FirstCall/ --,Genzyme ... study of,Renvela(TM) (sevelamer carbonate) achieved its primary ... for hyperphosphatemic patients with chronic kidney,disease who ... with Renvela also achieved a significant,reduction in ...
Cached Medicine Technology:Novelos Therapeutics and MUSC Present Two Posters at AACR 2007,Annual Meeting 2Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 2Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 3
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 The ... its readers reviews of affordable skin care products, recently ... casual blog offers readers a wide variety of articles, ... as well as organic skincare alternatives. , According to ... Care Journal’s main content includes thoroughly researched reviews, tips ...
(Date:11/24/2014)... Abington Health is pleased to ... The Neurology Group and has been named associate medical ... A graduate of Vinnica Medical University in Ukraine, Ternopolska ... Center in Philadelphia and completed a fellowship in Multiple ... Weill Cornell Medical College. Ternopolska is board certified in ...
(Date:11/24/2014)... 2014 Recently, SweetDressy.com, a well-known dress ... new collection of 2014 Evening Dresses. All these fresh ... the company’s marketing manager, the special offer is valid ... more. , Sweetdressy.com has been working well in the ... the latest designs. Their new dresses may be the ...
(Date:11/24/2014)... TX (PRWEB) November 24, 2014 The ... all of the wrong ingredients. Consistently consuming a diet ... to develop stores of excess fat that typically accumulate ... problems and rearing its ugly head in the form ... , When dieters make the decision to rid themselves ...
(Date:11/24/2014)... 2014 Dr. Michael Kettel , a ... appeared on NBC to discuss egg freezing as a viable ... trending in the news recently, with new company benefits at ... , “[The companies] see it as a way ... career hot path.” Says Dr. Kettel. , Up until a ...
Breaking Medicine News(10 mins):Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3
... of the digestive disorder have slightly higher death rate, study ... milder symptoms of celiac disease face a slightly higher risk ... Cancer and heart disease were the main causes of death ... people who had had small-intestinal biopsies in childhood, the researchers ...
... expects first batches to be available within a month , ... Drug Administration on Tuesday approved four new H1N1 swine flu ... four weeks. , "Today,s approval is good news for our ... Dr. Margaret A. Hamburg said in a news release. "This ...
... , WASHINGTON, Sept. 15 The American ... impact on health care issues conducted by Pulse Opinion Research, LLC, ... of Americans believe that high immigration levels have had an adverse ... Republicans (89%) felt more strongly on the issue, but Democrats ...
... Cowen Group, Inc. (Nasdaq: COWN ) announced today that ... the Investment Banking Group to lead the Firm,s medical technology practice. ... to Peter Reikes, Head of Cowen,s Health Care Investment Banking group. ... of health care investment banking experience and joins Cowen most recently ...
... ... Business , ... (Vocus) September 15, 2009 -- Health Advocate, the nation’s leading independent healthcare advocacy and assistance ... to meet the needs of its growing business. With the addition of a new ...
... SARASOTA Fla., Sept. 15 A most unusual home health care firm ... think they can do. , , When an ... members often are thrust into their first experience with home health care. ... the caregivers simply react to problems, and expectations are low. Her people ...
Cached Medicine News:Health News:FDA Approves 4 Swine Flu Vaccines 2Health News:FDA Approves 4 Swine Flu Vaccines 3Health News:FDA Approves 4 Swine Flu Vaccines 4Health News:National Poll Finds Most Americans Believe Immigration Adversely Affects the Quality and Cost of Healthcare 2Health News:Cowen Announces Hiring of Don Munoz to Lead Medical Technology Practice; 5th Senior-Level Addition to Cowen's Health Care Franchise in 2009 2Health News:Health Advocate, Inc. Expands Headquarters 2Health News:Health Advocate, Inc. Expands Headquarters 3Health News:Seniors May Think They Can't, But They Can 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: